Skip to main content
Patients say pharma's engagement efforts falling short
8/13/2019

Patients responding to an Accenture survey said drugmakers don't engage patients as well as advocacy groups do and said drugmakers should partner with such groups. Accenture surveyed 4,000 patients in the US and Europe who had rheumatoid arthritis, migraines or chronic lymphocytic leukemia, and 84% supported the idea of drugmakers and advocacy groups working together.

Full Story: